Consumer Defensive
Covista Inc(CVSA)
Live Price
Offline$119.07
+1.47% today
Window Change
+4.01%
Window
May 5, 2026 โ Jun 24, 2026
- Market Cap
- $4.07B
- Revenue Growth
- +12.9%
- EPS Growth
- +79.7%
- Dividend Yield
- 0.0%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 35 bars ยท May 5, 2026 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Covista Inc (CVSA) is a Consumer Defensive stock with a market cap of $4.07B and listed on NYSE. The stock last traded around $119.07 and up 4.0% across the available one-year price window (May 5, 2026 โ Jun 24, 2026). Baseline metrics include revenue growth of +12.9%, EPS growth of +79.7%, a dividend yield of 0.0%. What stands out right now is revenue +12.9%, EPS +79.7%, free cash flow +16.5% with operating margin 19.3% and ROIC 12.8%. Valuation is more restrained than many high-expectation growth names at P/E 17.0 and price/sales 2.2. Stock Foundry combines CVSA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+12.9% vs +1.7% peer median
Operating Margin
Above sector median
+19.3% vs +6.6% peer median
P/E
Above sector median
17.0 vs 14.0 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +12.9% and EPS at +79.7%, with operating margin around 19.3%.
Benchmark Edge
CVSA vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CVSA
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CVSA Max Drawdown
-12.26%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CVSA and SPY.
Company Overview
Covista Inc
NYSE
Adtalem Global Education Inc. is a premier educational services company focused on empowering students to achieve their academic and career goals. Specializing in providing undergraduate, graduate, and professional degrees, Adtalem operates through a network of institutions and is involved in various sectors, including healthcare, business management, and legal education. The organization is committed to increasing access to educational opportunities, equipping students with the skills necessary for a global workforce. Noteworthy institutions under the Adtalem umbrella include the Chamberlain University, known for its nursing programs, and the Ross University School of Medicine, supporting medical education. Through these entities, Adtalem not only addresses the significant demand for skilled professionals but also contributes to societal needs with its healthcare and business-oriented programs. Adtalem plays a critical role in the financial market by catering to an ever-present need for professional education, aligning with industry requirements and workforce development trends. As the demand for qualified professionals continues to rise, Adtalem's strategic positioning in the education sector underscores its importance and resilience in the market.
- Leadership
- Mr. Stephen W. Beard J.D.
- Employees
- 4.7k
- Street Address
- 233 South Wacker Drive, Suite 800
- Mailing
- Chicago, IL, 60606
- Region
- Chicago, IL, United States
- Last Updated
- May 9, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 17.0
- EV/EBITDA
- 11.1
- Price/Sales
- 2.2
- Price/Book
- 3.1
Growth
- Revenue
- +12.9%
- EPS
- +79.7%
- Free Cash Flow
- +16.5%
Profitability
- Gross Margin
- 57.4%
- Operating Margin
- 19.3%
- Net Margin
- 13.4%
- ROE
- 17.8%
- ROIC
- 12.8%
Balance Sheet
- Debt/Equity
- 0.53
- Current Ratio
- 0.68
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.